XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 1 $ 103,396 $ (79,519) $ 23,878
Balance, shares at Dec. 31, 2022 1,334,950      
Issuance of shares for restricted stock units
Issuance of shares for restricted stock units, shares   8,588      
Issuance of shares in reverse stock split (for fractional shares)
Issuance of shares in reverse stock split (for fractional shares), shares   24,090      
Issuance of common stock and warrants, under registered public offering $ 1 1
Issuance of common stock and warrants, under registered public offering, shares.   150,000      
Stock based compensation 1,045   1,045
Net Loss (20,131) (20,131)
Balance at Dec. 31, 2023 $ 2 104,441 (99,650) 4,793
Balance, shares at Dec. 31, 2023 1,517,628      
Issuance of shares for restricted stock units
Issuance of shares for restricted stock units, shares   4,771      
Stock based compensation 1,019 1,019
Net Loss (17,759) (17,759)
Exercise of pre-funded warrants $ 1 (1)
Exercise of pre-funded warrants, shares   1,055,000      
Conversion of Series B-1 Preferred (mezzanine) into Series B-2 Preferred and common stock $ 4 3,566 3,570
Conversion of Series B-1 Preferred (mezzanine) into Series B-2 Preferred and common stock, shares 3,790 3,952,393      
Issuance of Series B-3 Preferred upon exercise of warrants 12,810 12,810
Issuance of Series B-3 Preferred upon exercise of warrants, shares 7,998        
Conversion of Series B-2 and B-3 Preferred into common stock $ 2 (2)
Conversion of Series B-2 and B-3 Preferred into common stock, shares (1,659) 2,344,140      
Balance at Dec. 31, 2024 $ 9 $ 121,833 $ (117,409) $ 4,433
Balance, shares at Dec. 31, 2024 10,129 8,873,932